A. Plotnikova
4 Papers
A. Plotnikova is an academic researcher. The author has contributed to research in topics: Medicine & Internal medicine. The author has co-authored 1 publications.
Chat about Author
Papers
Pos0624 efficacy and safety of levilimab in combination with methotrexate in subjects with active rheumatoid arthritis: phase iii, double-blind, placebo-controlled, randomized trial
V. Mazurov,Maxim Aleksandrovich Korolev,A. Kundzer,N. Soroka,A. Kastanayan,T. Povarova,T. Plaksina,O. Antipova,D. Kretchikova,S. Smakotina,O. Tciupa,T. Raskina,T. Kropotina,O. Nesmeyanova,T. Popova,E. Dokukina,A. Plotnikova,A. Lutskii,A. Zinkina-Orihan +18 more
TL;DR: The study confirmed superior efficacy of levilimab +MTX over placebo + MTX in subjects with MTX resistant active RA.
3
1013: outcome from spontaneous intraparenchymal hemorrhage during critical care resuscitation unit stay
Milana Shapsay,Nahom Seyoum,Abigail J. Kim,A. Plotnikova,Yiting Lin,Alexa Aquino,Robinson Okolo,Tesia Shi,Aditi Singh,Anastasia Ternovskaia,Jerry Yang,Fernando Abelo,Samantha Asunción,Amanda Tuchler,Erin Niles,Ann Matta,Daniel Haase,David Dreizin,Hassan Syed,Quincy K. Tran +19 more
TL;DR: In this article , the authors used multivariable stepwise logistic regression with Box-Cox transformation to normalize continuous components of BPV, namely Standard Deviation and Successive Variation in SBP (SBPSD) and SBPSV, in patients with spontaneous intraparenchymal hemorrhage.
Pos0649 efficacy and safety of levilimab in combination with methotrexate in patients with active rheumatoid arthritis: 1-year results of phase iii, double-blind, placebo-controlled, randomized trial
V. Mazurov,M. Korolev,Andrey Pristrom,A. Kundzer,N. Soroka,Aleksander Kastanayan,Tatyana Povarova,T. Plaksina,O. V. Antipova,Diana Kretchikova,Svetlana A Smakotina,Oksana Tciupa,Ekaterina Puntus,T Raskina,L.N. Shilova,T. Kropotina,O. Nesmeyanova,T. Popova,Irina Vinogradova,I. Linkova,A. Plotnikova,P. Pukhtinskaia,A V Zinkina-Orikhan,A. Eremeeva,A. Lutckii +24 more
TL;DR: 1-year efficacy and safety data of the open-label period of the SOLAR study of levilimab in combination with methotrexate in subjects with MTX resistant active RA is presented.
Efficacy and safety of levilimab in combination with methotrexate in patients with active rheumatoid arthritis: 56-week results of phase III randomized double-blind placebo-controlled trial SOLAR
V. Mazurov,A M Lila,Maxim Aleksandrovich Korolev,A. Prystrom,A. Kundzer,N. Soroka,Aleksander Kastanayan,Tatyana Povarova,T. Plaksina,O. V. Antipova,Diana G Krechikova,Svetlana A Smakotina,Oksana Tciupa,E. V. Puntus,T. A. Raskina,L.N. Shilova,T. Kropotina,O. Nesmeyanova,T. Popova,I. B. Vinogradova,E. Dokukina,A. Plotnikova,P. Pukhtinskaia,A V Zinkina-Orikhan,Yu N Lin'kova,A. Eremeeva,A. Lutckii,E. Nasonov +27 more
TL;DR: In this article , the authors evaluated the efficacy and safety of levilimab in combination with methotrexate (MTX) in subjects with MTX resistant active rheumatoid arthritis.